Abnormal Cerebrospinal Fluid Morphology C0151583
Abnormalities in the fluid surrounding the brain and spinal cord. May indicate infection, bleeding, or other neurological conditions.
Key facts at a glance
- ICD-10
- G43.909
- ICD-11
- 8A00.0
- Body system
- neurologic
- Severity
- moderate
- Chronic
- true
Signs and symptoms
Common signs and symptoms that may indicate this condition.
Warning signs - seek immediate care
Altered mental status
Changes in consciousness, confusion, disorientation, or decreased alertness indicating significant central nervous system involvement.
This is a medical emergency. Seek immediate emergency care if experiencing confusion, drowsiness, or loss of consciousness.
Seizures
Sudden, uncontrolled electrical disturbances in the brain causing convulsions, loss of consciousness, or involuntary movements.
This is a medical emergency. Call emergency services immediately if a seizure occurs.
Headache
(neurologic)Persistent, often severe headache that may worsen when lying down or with changes in position, commonly associated with increased intracranial pressure.
Frequency: 70-90% of patients
Neck stiffness
(neurologic)Stiffness and inability to flex the neck forward, indicating meningeal irritation from inflammation or infection.
Frequency: 60-80% of patients
Fever
(constitutional)Elevated body temperature often indicating underlying infection or inflammatory process affecting the central nervous system.
Frequency: 65-85% of patients
Nausea with vomiting
(gastrointestinal)Feeling of sickness with urge to vomit, often resulting from increased intracranial pressure affecting the vomiting center.
Frequency: 30-50% of patients
Photophobia
(neurologic)Increased sensitivity to light causing discomfort or pain, commonly associated with meningeal irritation.
Frequency: 25-45% of patients
Fatigue
(constitutional)Persistent tiredness and lack of energy that may persist even after rest, common with infectious or inflammatory conditions.
Frequency: 30-50% of patients
Diagnosis and tests
How this condition is diagnosed and what test results mean.
Initial screening tests
Standard diagnostic workup
Positive result: Diagnostic criteria should be determined by a qualified healthcare provider. [Content pending medical review.]
Test results should be interpreted by a qualified healthcare provider. [Content pending medical review.]
Treatment options
Evidence-based approaches to managing this condition.
First-line treatments
Exercise prescription and weight management
Treatment options should be discussed with a qualified healthcare provider.
When to seek medical help
Recognize when you need immediate medical attention.
Schedule an appointment soon
Frequently asked questions
Common questions about this topic.
What is Abnormal Cerebrospinal Fluid Morphology C0151583?
Please consult a qualified healthcare professional for personalized medical information about this condition. [Content pending medical review.]
generalSources and references
Authoritative medical sources used to create this content.
Teunissen CE, Petzold A, Bennett JL, et al. A consensus protocol for the standardization of cerebrospinal fluid collection and biobanking. Neurology. 2009;73(22):1914-1922.
Sailer M, Rieckmann P. Cerebrospinal fluid analysis in neurological diseases. Dtsch Arztebl Int. 2011;108(45):761-766.
Andersen O. Cerebrospinal fluid in the diagnosis of multiple sclerosis. Front Neurol. 2021;12:719407.
Luo C, Chen J, Li Q, et al. Cerebrospinal fluid biomarkers for neurological disorders: a systematic review and meta-analysis. Front Neurol. 2022;13:857953.
Kuhle J, Barro C, Andreasson U, et al. Comparison of three analytical platforms for quantification of the neurofilament light chain biomarker in blood. Clin Chem Lab Med. 2016;54(10):1655-1661.
Thompson EJ, Keir G. CSF analysis: a practical approach to laboratory diagnosis. Pract Neurol. 2015;15(5):322-330.
Deisenhammer F, Bartos A, Egg R, et al. Guidelines on routine cerebrospinal fluid analysis. Report from an EFNS task force. Eur J Neurol. 2006;13(9):913-922.
Fishman RA. Cerebrospinal Fluid in Diseases of the Nervous System. 2nd ed. Philadelphia: WB Saunders; 1992.
Walton C, Kalff A, Malladi CS, et al. British Society for Rheumatology guideline for the management of Vogt-Koyanagi-Harada disease. Rheumatology (Oxford). 2021;60(12):5484-5494.
Bjursten S, Abdo AA, Al-Mansour Z, et al. Multicenter evaluation of cerebrospinal fluid biomarkers for tuberculous meningitis. J Clin Microbiol. 2023;61(1):e0123422.
Medication Comparisons
Compare medications used to treat Abnormal Cerebrospinal Fluid Morphology C0151583. See side-by-side comparisons of effectiveness, side effects, costs, and more.
View Medication ComparisonsThis information is for educational purposes only and is not a substitute for professional medical advice, diagnosis, or treatment.
This content is for general informational and educational purposes only and is not a substitute for professional medical advice, diagnosis, or treatment. Always seek the guidance of a qualified healthcare provider with any questions you have about a medical condition, and never disregard professional medical advice or delay seeking it because of something you read here.
If you think you may have a medical emergency, call your local emergency number or go to the nearest emergency department immediately.
Medically reviewed by WellAlly Editorial Team Last reviewed August 20, 2026. · Read our editorial policy